样式: 排序: IF: - GO 导出 标记为已读
-
Minimally Invasive Approach versus Sternotomy for Bentall Procedure: A Single-Center Experience J. Interv. Cardiol. (IF 2.1) Pub Date : 2024-3-27 Hong-Peng Zou, Feng Lu, Xiang Long, Shu-Qiang Zhu, Kun Lin, Bai-Quan Qiu, Xin Yang, Jian-Jun Xu, Yong-Bing Wu
Background. The need for minimally invasive Bentall surgery for the treatment of aortic lesions with aortic insufficiency is increasing; however, comparative studies on the safety of the minimally invasive Bentall procedure and sternotomy Bentall procedure are lacking. Methods. Clinical data of 56 patients who underwent the Bentall procedure performed by the same surgical team at our center between
-
Meta-Analysis of Randomized Trials: Efficacy and Safety of Colchicine for Secondary Prevention of Cardiovascular Disease J. Interv. Cardiol. (IF 2.1) Pub Date : 2024-3-12 Elie Akl, Nazanin Sahami, Christopher Labos, Jacques Genest, Ali Zgheib, Nicolo Piazza, Sanjit Jolly
Background. Colchicine has shown potential cardioprotective effects owing to its broad anti-inflammatory properties. We performed a meta-analysis to assess its safety and efficacy in secondary prevention in patients with established coronary artery disease (CAD). Methods. We searched Ovid Healthstar, MEDLINE, and Embase (inception to May 2022) for randomized controlled trials (RCTs) evaluating the
-
Effect of Neutrophil-to-Lymphocyte Ratio on Post-TAVR Mortality and Periprocedural Pulmonary Hypertension J. Interv. Cardiol. (IF 2.1) Pub Date : 2024-2-20 Xin Gao, Xiaoxiao Jiang, Zonglei Wu, Na Chen, Minghui Gong, Xu Zhao, Yan Liu, Ran Guo
Aims. To evaluate the impact of neutrophil-to-lymphocyte ratio (NLR) on periprocedural pulmonary hypertension (PH) and 3-month all-cause mortality in patients with aortic stenosis (AS) who underwent transcatheter aortic valve replacement (TAVR) and to develop a nomogram for predicting the mortality for these patients. Methods and Results. 124 patients undergoing TAVR were categorized into three groups
-
Examining the Outcomes of Hybrid Coronary Revascularization in Acute STEMI Patients from 2015 to 2022 J. Interv. Cardiol. (IF 2.1) Pub Date : 2024-2-8 Mozhgan Bahramian, Seyed Ali Moezi bady, Maryam Bahramian, Ahmad Amouzeshi
Background. The global rise of chronic diseases, especially cardiovascular disease (CVD), poses a significant public health challenge, being a leading cause of death and disability worldwide. In Iran, the surge in CVD incidence and its risk factors, along with a decrease in the age of onset, has notably increased the reliance on coronary artery bypass grafting (CABG) as a life-saving intervention.
-
Clinical and Laboratory Predictors of Long-Term Outcomes after Catheter Ablation for a Ventricular Electrical Storm J. Interv. Cardiol. (IF 2.1) Pub Date : 2024-2-5 Grzegorz Sławiński, Maja Hawryszko, Julia Dyda-Kristowska, Tomasz Królak, Maciej Kempa, Dariusz Świetlik, Dariusz Kozłowski, Ludmiła Daniłowicz-Szymanowicz, Ewa Lewicka
Background. Ventricular electrical storm (VES) is characterized by the occurrence of multiple episodes of sustained ventricular arrhythmias (VA) over a short period of time. Radiofrequency ablation (RFA) has been reported as an effective treatment in patients with ventricular tachycardia (VT). Objective. The aim of the present study was to indicate the short-term and long-term predictors of recurrent
-
Comparison of Ticagrelor and Clopidogrel in Elective Coronary Stenting: A Double Blind Randomized Clinical Trial J. Interv. Cardiol. (IF 2.1) Pub Date : 2023-12-26 Mohammadjavad Mehdizadeh Parizi, Reza Golchin Vafa, Amin Ahmadi, Reza Heydarzade, Mehrdad Sadeghi, Amin Khademolhossseini, Farhang Amiri, Soroush Khoshnood Mansorkhani, Ali Tavan, Nazanin Hosseini, Mohammad Montaseri, Seyed Ali Hosseini, Javad Kojuri
Background. Dual antiplatelet therapy with a P2Y12 inhibitor (e.g., clopidogrel and ticagrelor) and aspirin is recommended for at least one year after percutaneous coronary intervention (PCI) to prevent further myocardial infarction and stent thrombosis as the major adverse effects of PCI. Methods. This randomized clinical trial was conducted from October 2022 to March 2023. Patients who had undergone
-
Mitral Valve Transcatheter Edge-to-Edge Repair Volumes and Trends J. Interv. Cardiol. (IF 2.1) Pub Date : 2023-12-19 Kris Kumar, Timothy F. Simpson, Harsh Golwala, Adnan K. Chhatriwalla, Scott M. Chadderdon, Robert L. Smith, Howard K. Song, Ryan R. Reeves, Paul Sorajja, Firas E. Zahr
Background. Despite an association between operator volumes and procedural success, there remains an incomplete understanding of the contemporary utilization and procedural volumes for mitral valve transcatheter edge-to-edge repair (MTEER). We aimed to identify annual operator procedural volumes, temporal trends, and geographic variability for MTEER among Medicare patients in the United States (US)
-
In-Hospital and 1-Year Clinical Results from the French Registry Using Polymer-Free Sirolimus-Eluting Stents in Acute Coronary Syndrome and Stable Coronary Artery Disease J. Interv. Cardiol. (IF 2.1) Pub Date : 2023-12-13 Quentin Landolff, Marine Quillot, Fabien Picard, Patrick Henry, Georgios Sideris, Olivier Bizeau, Christophe Piot, Bernard Jouve, Jérôme Rischner, Mourad Mejri, Claude Charmasson, Raphael Lasserre, Hervé Pouliquen, Thierry Joseph, Jacques Monsegu, Bernard Karsenty, Victoria Martin Yuste, Nicolas Richet, Guy Lapeyre, Fabrizio Beverelli, Farzin Beygui, René Koning
Objectives. The aim of this postmarket clinical study was to assess the safety and efficacy of the latest generation polymer-free sirolimus-eluting stents (PF-SES) in an all-comers population comparing outcomes in stable coronary artery disease (CAD) versus acute coronary syndrome (ACS) in France. Background. The efficacy and safety of the first-generation PF-SES have already been demonstrated by randomized
-
Neo-Commissural Alignment by Withdrawing and Readvancing the Delivery System during Transcatheter Aortic Valve Replacement with Self-Expanding Prosthesis J. Interv. Cardiol. (IF 2.1) Pub Date : 2023-12-11 Xian Liu, Yingdong Wang, Yuhe Sheng, Yaling Han, Quanmin Jing, Geng Wang, Zhenyang Liang, Yang Li, Bin Wang, Kai Xu, Li Yang, Gary S. Mintz
Objective. To investigate the feasibility of obtaining neo-commissural alignment by withdrawing and readvancing the delivery system during transcatheter aortic valve replacement (TAVR) with self-expanding prosthesis. Methods. TAVR was performed in five patients with severe aortic valve stenosis by the femoral approach. The delivery catheter was withdrawn and readvanced with the opposite orientation
-
Global Research Hotspots in Venous Thromboembolism Anticoagulation: A Knowledge-Map Analysis from 2012 to 2021 J. Interv. Cardiol. (IF 2.1) Pub Date : 2023-11-17 Jia Wang, Yang-Xi Liu, Yi-Dan Yan, Li Liu, Chi Zhang, Mang-Mang Pan, Hou-Wen Lin, Zhi-Chun Gu
Background. Venous thromboembolism (VTE) is a common cardiovascular disease that seriously threatens human lives. Anticoagulant therapy is considered to be the cornerstone of VTE treatment. An increasing number of studies has been updated in the VTE anticoagulation field. However, no bibliometric analyses have assessed these publications comprehensively. Therefore, our study aimed to analyze the global
-
Center Volumes Correlate with Likelihood of Stent Implantation in German Coronary Angiography J. Interv. Cardiol. (IF 2.1) Pub Date : 2023-11-9 Vera Oettinger, Philip Hehn, Christoph Bode, Manfred Zehender, Constantin von zur Mühlen, Dirk Westermann, Peter Stachon, Klaus Kaier
Aims. Literature on percutaneous coronary intervention (PCI) stated an inverse relationship between hospital volume and mortality, but the effects on other characteristics are unclear. Methods. Using German national records, all coronary angiographies with coronary artery disease in 2017 were identified. We applied risk-adjustment to account for differences in population characteristics. Results. Of
-
Percutaneous Coronary Intervention versus Coronary Artery Bypass Grafting for Chronic Total Occlusion of Coronary Arteries: A Systematic Review and Meta-Analysis J. Interv. Cardiol. (IF 2.1) Pub Date : 2023-11-6 Chenyang Wang, Sheng Liu, Raimov Kamronbek, Siyao Ni, Yunjiu Cheng, Huiyuan Yan, Ming Zhang
Introduction. Chronic total occlusion (CTO) of coronary arteries constitutes a substantial clinical challenge and has historically been managed through medical management and coronary artery bypass grafting (CABG). However, with the advancement in interventional technology, the success rate of percutaneous treatment has been significantly improved, and percutaneous coronary intervention (PCI) has emerged
-
Therapy Efficacy of Idiopathic Ventricular Extrasystoles: A Real Life Study J. Interv. Cardiol. (IF 2.1) Pub Date : 2023-10-27 Aliisa Lönnrot, Jaakko Inkovaara, Olli Arola, Tero Penttilä, Heikki Mäkynen, Katriina Aalto-Setälä, Sinikka Yli-Mäyry
Background. Ventricular extrasystoles (VESs) are common and often harmless in a healthy heart, but they can significantly affect the quality of life. If changes in lifestyle and antiarrhythmic medication are not enough, invasive and often curative catheter ablation can be considered. Better understanding of the conformation of VESs with a 12-lead ECG, as well as their precise localization, have increased
-
The Differences of Quantitative Flow Ratio in Coronary Artery Stenosis with or without Atrial Fibrillation J. Interv. Cardiol. (IF 2.1) Pub Date : 2023-10-13 Wenbin Lu, Xiaoguo Zhang, Gaoliang Yan, Genshan Ma
Quantitative flow ratio (QFR) is a new method for the assessment of the extent of coronary artery stenosis. But it may be obscured by the cardiac remodeling and abnormal blood flow of the coronary artery when encountering atrial fibrillation (AF). The present study aimed to examine the impact of these changed structures and blood flow of coronary arteries on QFR results in AF patients. Methods and
-
Temporal Trends and Early Outcomes of Transcatheter versus Surgical Mitral Valve Repair in Atrial Fibrillation Patients J. Interv. Cardiol. (IF 2.1) Pub Date : 2023-10-12 Chi Zhou, Kai Tan, Weili Liu, Shaohua Li, Zongyi Xia, Yanxu Song, Zhexun Lian
Objectives. To study trends of utilization, in-hospital outcomes, and short outcomes in patients undergoing transcatheter mitral valve repair (TMVR) vs. surgical mitral valve repair (SMVR) in atrial fibrillation (AF). Background. TMVR is a treatment option in inoperable or high-risk patients with mitral regurgitation (MR). AF is a common comorbidity of MR. Data comparing between TMVR and SMVR in MR
-
Predictive Value of Post-Percutaneous Coronary Intervention Quantitative Flow Ratio for Vessel-Oriented Composite Endpoint J. Interv. Cardiol. (IF 2.1) Pub Date : 2023-9-9 Weibin Liu, Huaxiu Cai, Yin Zheng, Yongkang Wen, Sicheng Chen, Xiuying Xie, Huan Zeng, Hengqing Zhu, Zhonghan Ni, Fang Pei, Jun Cao, Gang Cao
At present, there is a lack of indicators, which can accurately predict the post-percutaneous coronary intervention (post-PCI) vessel-oriented composite endpoint (VOCE). Recent studies showed that the post-PCI quantitative flow ratio (QFR) can predict post-PCI VOCE. PubMed, Embase, and Cochrane were searched from inception to March 27, 2022, and the cohort studies about that the post-PCI QFR predicts
-
Lower Plasma miR-223 Level Is Associated with Clopidogrel Resistance in Acute Coronary Syndrome: A Systematic Review and Meta-Analysis J. Interv. Cardiol. (IF 2.1) Pub Date : 2023-8-17 Hang Cheng, Min Yang, Junli Hao, Kejie Chen, Quandan Tan, Song He, Fengkai Mao, Ming Yang, Yapeng Lin, Jie Yang
Objectives. To evaluate the relationship between the plasma miR-223 expression level and clopidogrel resistance in acute coronary syndrome (ACS) patients. Methods. We performed a search for publications using online databases including PubMed, EMBASE, Cochrane Library, and Chinese Databases (CNKI database, Weipu database, and Wanfang database) from the inception of the databases to June 18, 2023, to
-
Comparative Analysis of Single-Path and Multipath Adrenal Venous Sampling in Primary Aldosteronism J. Interv. Cardiol. (IF 2.1) Pub Date : 2023-8-12 Zhoufei Fang, Han Cai, Qixiang Zhang, Jin Gong, Wei Zhou, Liangdi Xie, Feng Peng
Objective. To evaluate the safety and efficacy of adrenal venous sampling (AVS) via the cubital vein and femoral vein synchronously. Methods. A total of 200 patients with primary aldosteronism admitted to the First Hospital of Fujian Medical University were enrolled and randomly divided into a single-path AVS group (SP, N = 108) and a multipath AVS group (MP, N = 92). We analyzed the clinical characteristics
-
SUOH 03 Guidewire for the Management of Coronary Artery Dissection: Insights from a Multicenter Registry J. Interv. Cardiol. (IF 2.1) Pub Date : 2023-8-1 Gabriele L. Gasparini, Mario Bollati, Mauro Chiarito, Michele Cacia, Fausto Roccasalva, Claudiu Ungureanu, Giuseppe Colletti, Simone Muraglia, Pierluigi Merella, Fabrizio Ugo, Andrea Pacchioni, Salvatore Colangelo, Jorge Sanz Sanchez, Pier Pasquale Leone, Azeem Latib, Pietro Mazzarotto
Background. In the setting of coronary artery dissection, both spontaneous and iatrogenic, fixing the intimal tear, usually with stent implantation, can be extremely challenging if the distal wire position has been lost. Common complications are mainly related to the inadvertent subintimal tracking of the guidewire while attempting to gain the distal true lumen. Aims. To report the registry results
-
Resting Full-Cycle Ratio versus Fractional Flow Reserve: A SWEDEHEART-Registry-Based Comparison of Two Physiological Indexes for Assessing Coronary Stenosis Severity J. Interv. Cardiol. (IF 2.1) Pub Date : 2023-6-29 Stephen Malmberg, Jörg Lauermann, Patric Karlström, Dario Gulin, Neshro Barmano
The adenosine-requiring physiological index fractional flow reserve (FFR) is the gold-standard method for determining the significance of intermediate lesions, while the resting full-cycle ratio (RFR) is a novel nonhyperaemic index without the need for adenosine administration. The aim of this study was to investigate the degree of concordance between RFR and FFR in indicating the need for revascularisation
-
The Value of the Cardiac Magnetic Resonance Intravoxel Incoherent Motion Technique in Evaluating Microcirculatory Dysfunction in Hypertrophic Cardiomyopathy J. Interv. Cardiol. (IF 2.1) Pub Date : 2023-6-28 Alina Abulaiti, Quan Zhang, Haiyan Huang, Shuang Ding, Miriguli Shayiti, Shaoyu Wang, Yunling Wang, Wenxiao Jia
Objective. To evaluate the value of the cardiac magnetic resonance intravoxel incoherent motion (IVIM) technique in microcirculatory dysfunction in patients with hypertrophic cardiomyopathy (HCM). Methods. The medical records of 19 patients with HCM in our hospital from January 2020 to May 2021 were collected retrospectively, and 23 healthy people with a similar age and gender distribution to the patients
-
Drug-Coated Balloon in Primary Percutaneous Coronary Intervention J. Interv. Cardiol. (IF 2.1) Pub Date : 2023-6-26 Hui Zhao, Runran Miao, Fei Lin, Guoan Zhao
According to the latest coronary interventional guidelines, a drug-eluting stent is the recommended reperfusion therapy in primary percutaneous coronary intervention (pPCI). However, deficiencies and defects, such as in-stent restenosis (ISR), incomplete stent apposition, stent thrombosis, reinfarction after stent implantation, long-term dual antiplatelet drug use, and adverse reactions of metal implants
-
Impact of New-Onset Conduction Disturbances following Transcatheter Aortic Valve Replacement on Outcomes: A Single-Center Study J. Interv. Cardiol. (IF 2.1) Pub Date : 2023-5-31 Claudia See, Yanting Wang, Haocheng Huang, Helen Parise, Yiping Yang, Daniela Tirziu, Dominic P. Francese, Nikolaos Papoutsidakis, Eric Bader, Ryan K. Kaple, Michael Cleman, Alexandra J. Lansky, John K. Forrest
Background. Transcatheter aortic valve replacement (TAVR) is known to increase the incidence of conduction disturbances compared to surgical aortic valve replacement; however, there are limited data on the impact and duration of these conduction disturbances on longer term outcomes. Objective. To determine the differential impact of persistent versus nonpersistent new-onset conduction disturbances
-
P2Y12 Inhibitors in Acute Coronary Syndromes: A Real-World, Community-Based Comparison of Ischemic and Bleeding Outcomes J. Interv. Cardiol. (IF 2.1) Pub Date : 2023-5-20 Amit Sachdeva, Ratnabhushan Mutyala, Neha Mantri, Shiyun Zhu, Edward McNulty, Matthew Solomon
Background. Randomized trials have shown superiority of the novel P2Y12 inhibitors over clopidogrel in patients with acute coronary syndrome (ACS), but clinical benefit in the community remains controversial. Our objective was to compare the safety and efficacy of clopidogrel to ticagrelor and prasugrel in patients with ACS undergoing percutaneous coronary intervention (PCI) in a real-world population
-
Application of Nanoliposome Alprostadil in the Perioperative Period of Percutaneous Coronary Intervention to Reduce In-Stent Restenosis: A Systematic Review and Meta-Analysis J. Interv. Cardiol. (IF 2.1) Pub Date : 2023-5-18 Decai Zhu, Dawei Wang, Zhen Zhao, Qingqing Liu, Rongyuan Yang, Qing Liu
Background. In-stent restenosis (ISR) is a common complication after percutaneous coronary intervention (PCI) surgery for patients with coronary atherosclerotic heart disease (CHD). Reports indicate alprostadil may reduce ISR, and this study aimed at reviewing and summarizing the effect of nanoliposome alprostadil on ISR by meta-analysis. Methods. Articles were searched from databases, and meta-analysis
-
Learning Curve Analyses for Left Bundle Branch Area Pacing with Conventional Stylet-Driven Pacing Leads J. Interv. Cardiol. (IF 2.1) Pub Date : 2023-5-18 Ga-In Yu, Tae-Hoon Kim, Hee Tae Yu, Boyoung Joung, Hui-Nam Pak, Moon-Hyoung Lee
Background. Physiological conduction system pacing has attracted attention to overcome the dyssynchrony problems of conventional right ventricular pacing (RVP). Left bundle branch area pacing (LBBAP), which complements short combing of His bundle pacing (HBP), has emerged and has proven its efficiency and safety. In addition, initial experiences of LBBAP were mainly using lumen-less pacing lead, and
-
Practice Pattern Variation in Adoption of New and Evolving Percutaneous Coronary Intervention Procedures J. Interv. Cardiol. (IF 2.1) Pub Date : 2023-5-4 Diana Naranjo, Jacob Doll, Charles Maynard, Kristine Beaver, Aasthaa Bansal, Christian D. Helfrich
Objective. Assess factors contributing to variation in the use of new and evolving diagnostic and interventional procedures for percutaneous coronary intervention (PCI). Background. Evidence-based practices for PCI have the potential to improve outcomes but are variably adopted. Finding possible drivers of PCI procedure-use variability is key for efforts aimed at establishing more uniform practice
-
Self-Expanding Versus Balloon Expanding Coronary Stents in Intervention of the Degenerated Saphenous Vein Graft: Memmingen Coronary Artery Bypass Stenosis Trial (MECAST) J. Interv. Cardiol. (IF 2.1) Pub Date : 2023-4-6 Marcus Siry, Burak Duymaz, Simon Biesenberger, Deborah Siry, Vanessa Kammerer, Andreas E. May
Objectives. The aim of this retrospective analysis was to compare the patient outcome after interventional therapy of saphenous vein graft (SVG) stenoses in an all-comers population receiving either self-expanding drug-eluting stents (SExS) or balloon expanding drug-eluting stents (BExS). Background. The interventional therapy of degenerated SVGs remains challenging. Diameter variations of stenotic
-
Monitoring Spike Potential and Abrupt Impedance Rise with Concomitant Temperature/Contact Force Change for Timely Detection of the Occurrence of “Silent” or “Nonaudible” Steam Pop J. Interv. Cardiol. (IF 2.1) Pub Date : 2023-4-5 Chengye Di, Qun Wang, Yanxi Wu, Longyu Li, Wenhua Lin
Aim. Steam pop (SP) during radiofrequency catheter ablation (RFCA) for pulmonary vein isolation (PVI) may cause cardiac perforation, which may require drainage and emergent thoracotomy or even lead to death. Data investigating the timely detection of the occurrence of “silent” or “nonaudible” SP events are limited. Methods and Results. A total of 516 consecutive atrial fibrillation (AF) patients who
-
The “L-Sandwich” Strategy for True Coronary Bifurcation Lesions: A Randomized Clinical Trial J. Interv. Cardiol. (IF 2.1) Pub Date : 2023-3-21 Quan Guo, Liang Peng, Lixin Rao, Cao Ma, Kang Zhao, Zhenzhou Zhao, Haiyu Tang, Muwei Li
Background. This study explored the efficacy of the “L-sandwich” strategy, which involves the implantation of stents in the main vessel (MV) and shaft of the side branch (SB) with a drug-coated balloon (DCB) applied to the SB ostium, for coronary true bifurcation lesions. Methods and Results. Of 99 patients with true bifurcation lesions, 38 patients underwent the “L-sandwich” strategy (group A), 32
-
Effect of Radial Artery Compression with a Novel Automatic Pressure-Controlled Radial Compression Device: A Short-Term Prospective Interventional Pilot Study J. Interv. Cardiol. (IF 2.1) Pub Date : 2023-3-7 HaiZhen Xu, Junya Cheng, DanYing Zhang, Liang Shen, Yingjie Jiang, ChangLin Zhai
This study was conducted to design a novel radial compression device with the function of automatic pressure control and evaluate the feasibility and safety of this new technique. Patients who underwent transradial access (TRA) coronary angiography and percutaneous coronary intervention (PCI) in the First Hospital of Jiaxing between August 2021and October 2021 were prospectively enrolled in this pilot
-
Use of the Sheathless Eaucath Is an Effective Strategy to Overcome Resistant Severe Radial Spasm J. Interv. Cardiol. (IF 2.1) Pub Date : 2023-2-22 Andrew Borrie, Aditya Raina, Sarah Fairley, Anil Ranchord, Scott A. Harding
Objectives. We aimed to assess the effectiveness of the sheathless Eaucath guiding catheter (SEGC) in overcoming severe spasm. Background. Radial spasm is a frequent challenge in transradial access (TRA) and can be difficult to manage. Methods. We performed a prospective observational study of 1000 consecutive patients undergoing coronary angiography with or without percutaneous coronary intervention
-
Prophylactic ECMO Support during Elective Coronary Percutaneous Interventions in High-Risk Patients: A Single-Center Experience J. Interv. Cardiol. (IF 2.1) Pub Date : 2023-2-4 Claudiu Ungureanu, Marc Blaimont, Hugues Trine, Pierre Henin, Romain Courcelle, Yves Laurent, Patrick Van Ruyssevelt, Caroline Lepièce, Vincent Huberlant
Introduction. Evidence regarding the impact of prophylactic implantation of venoarterial extracorporeal membrane oxygenation (VA-ECMO) for elective high-risk percutaneous coronary intervention (PCI) is limited. The purpose of this paper is to evaluate the outcome during index hospitalization and 3 years after interventions. Methods. This is an observational retrospective study including all patients
-
Staged Percutaneous Management of Pulmonary Atresia and Intact Interventricular Septum: Stretching the Limits J. Interv. Cardiol. (IF 2.1) Pub Date : 2023-2-1 Sonia A. El-Saiedi, Wael A. Attia, Baher M. Hanna, Mahmoud O. Aboudeif, Rania Zakaria, Mohamad Abd ElMeguid, Ashraf Abd El Reheem, Reda Abuelatta
Aims. Pulmonary atresia with intact ventricular septum (PA/IVS) can be treated by catheter-based interventions and complemented by various surgical procedures. We aim to determine a long-term treatment strategy to enable patients to be surgery free, depending solely on percutaneous interventions. Methods and Results. We selected five patients from among a cohort of patients with PA/IVS treated at birth
-
Characteristics and Pattern of Calcified Nodule and/or Nodular Calcification Detected by Intravascular Ultrasound on the Device-Oriented Composite Endpoint (DoCE) in Patients with Heavily Calcified Lesions Who Underwent Rotational Atherectomy-Assisted Percutaneous Coronary Intervention J. Interv. Cardiol. (IF 2.1) Pub Date : 2023-1-21 Ploy Pengchata, Rungtiwa Pongakasira, Namthip Wongsawangkit, Asa Phichaphop, Nattawut Wongpraparut
Objectives. This study aimed to determine characteristics and pattern of a calcified nodule (CN) and/or nodular calcification (NC) detected by intravascular ultrasound (IVUS) on the device-oriented composite endpoint (DoCE) in patients with calcified lesions who underwent rotational atherectomy (RA)-assisted percutaneous coronary intervention (PCI). Background. The characteristics and pattern of a
-
Association of Radial Artery Access with Reduced Incidence of Acute Kidney Injury J. Interv. Cardiol. (IF 2.1) Pub Date : 2023-1-18 Patrick S. Kietrsunthorn, Tonja M. Locklear, Clifford E. Fonner, Chalak O. Berzingi, Jason R. Foerst, Mohd A. Mirza, David C. Sane, Eric Williams, Robert A. Shor, Gregory J. Dehmer
Objectives. To determine if radial artery (RA) access compared with femoral artery (FA) access for percutaneous coronary intervention (PCI) is associated with a lower incidence of acute kidney injury (AKI). Background. AKI results in substantial morbidity and cost following PCI. Prior studies comparing the occurrence of AKI associated with radial artery (RA) versus femoral artery (FA) access have mixed
-
Predilation Ballooning in High Thrombus Laden STEMIs: An Independent Predictor of Slow Flow/No-Reflow in Patients Undergoing Emergent Percutaneous Coronary Revascularization J. Interv. Cardiol. (IF 2.1) Pub Date : 2023-1-6 Rajesh Kumar, Danish Qayyum, Ifikhar Ahmed, Lajpat Rai, Ayaz Mir, Romana Awan, Ali Bin Naseer, Abdul Basit, Jawaid Akbar Sial, Tahir Saghir, Nadeem Qamar, Musa Karim
Background. Distal embolization due to microthrombus fragments formed during predilation ballooning is considered one of the possible mechanisms of slow flow/no-reflow (SF/NR). Therefore, this study aimed to compare the incidence of intraprocedure SF/NR during the primary percutaneous coronary intervention (PCI) in patients with high thrombus burden (≥4 grade) with and without predilation ballooning
-
Transcatheter Closure of Atrial Septal Defect with Carag Bioresorbable Septal Occluder™: First-in-Child Experience with 12-MonthFollow-Up J. Interv. Cardiol. (IF 2.1) Pub Date : 2022-12-30 Alessia Callegari, Daniel Quandt, Johannes Nordmeyer, Stephan Schubert, Peter Kramer, Walter Knirsch, Oliver Kretschmar
Background. Nowadays, transcatheter device closure of an atrial septal defect (ASD) is a standard approach in children. Potential early and long-term side effects or complications related to the metal framework of the devices are a known issue. A bioresorbable device such as the Carag Bioresorbable Septal Occluder™ (CBSO) could resolve such complications. Material and Results. The Carag Bioresorbable
-
Drug-Coated Balloons for Acute Myocardial Infarction: A Metaanalysis of Randomized Clinical Trials J. Interv. Cardiol. (IF 2.1) Pub Date : 2022-12-27 Yuxuan Zhang, Delong Chen, Qichao Dong, Yi Xu, Jiacheng Fang, Huaqing Zhang, Jun Jiang
Background. The role of a drug-coated balloon (DCB) in the treatment of acute myocardial infarction (AMI) is not well established. Methods. Five databases were searched for randomized controlled trials that compared DCB with stents in the treatment of AMI from their inception to 30 July 2021. The primary clinical endpoint was major adverse cardiac events (MACEs). Summary estimations were conducted
-
Long-Term Outcomes after Rotational Atherectomy for Calcified Chronic Total Occlusion versus Nonchronic Total Occlusion Coronary Lesions J. Interv. Cardiol. (IF 2.1) Pub Date : 2022-12-27 Karim Elbasha, Nader Mankerious, Mohamed Alawady, Ghada Ibrahim, Radwa Abdullah, Mohamed Abdel-Wahab, Rayyan Hemetsberger, Ralph Toelg, Gert Richardt, Abdelhakim Allali
Background. The role of rotational atherectomy (RA) in contemporary percutaneous coronary intervention (PCI) is expanding to include certain chronic total occlusion (CTO) lesions. However, the long-term outcome of RA in CTOs is still unclear. Objective. To investigate in-hospital and long-term outcomes after RA for CTO compared to non-CTO calcified lesions. Moreover, this report evaluates the role
-
Effects of PCSK9 Inhibition on Coronary Atherosclerosis Regression of Nontarget Lesions after Primary Percutaneous Coronary Intervention in Acute Coronary Syndrome Patients J. Interv. Cardiol. (IF 2.1) Pub Date : 2022-12-26 Yongjun Li, Mingming Yang, Xi Chen, Rui Zhang, Jing Li, Xiaoguo Zhang, Pengfei Zuo, Genshan Ma
Aims. To evaluate the regression of coronary atherosclerosis with proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibition in acute coronary syndrome (ACS) patients following primary percutaneous coronary intervention (PPCI). Methods and Result. We examined 40 nontarget lesions in 17 ACS patients who underwent PPCI and were treated with PCSK9 inhibitors. At 1 year, total cholesterol, low-density
-
Magnesium Bioresorbable Scaffold (BRS) Magmaris vs Biodegradable Polymer DES Ultimaster in NSTE-ACS Population—12-Month Clinical Outcome J. Interv. Cardiol. (IF 2.1) Pub Date : 2022-12-20 Piotr Rola, Adrian Włodarczak, Szymon Włodarczak, Mateusz Barycki, Marek Szudrowicz, Magdalena Łanocha, Łukasz Furtan, Katarzyna Woźnica, Jan Jakub Kulczycki, Joanna Jaroszewska-Pozorska, Michalina Kędzierska, Adrian Doroszko, Maciej Lesiak
Background. Percutaneous coronary intervention (PCI) in the acute coronary syndrome (ACS) setting is associated with a greater probability of device failure. The currently ongoing development of new scaffold technologies has concentrated an effort on improving the PCI outcomes, including the use of new biodegradable materials. This pilot study evaluates the performance of a magnesium bioresorbable
-
Edoxaban Monotherapy in Nonvalvular Atrial Fibrillation Patients with Coronary Artery Disease J. Interv. Cardiol. (IF 2.1) Pub Date : 2022-12-17 Daisuke Fukamachi, Yasuo Okumura, Naoya Matsumoto, Eizo Tachibana, Koji Oiwa, Makoto Ichikawa, Hironori Haruta, Kazumiki Nomoto, Ken Arima, Atsushi Hirayama
Background. Current guidelines recommend an oral anticoagulant (OAC) monotherapy in patients with nonvalvular atrial fibrillation (NVAF) and stable coronary artery disease (CAD) 1 year postpercutaneous coronary intervention (PCI). It might be possible to shorten the time for de-escalation from a dual therapy to monotherapy, but data regarding de-escalation to an edoxaban monotherapy are lacking. This
-
Correlation between Body Mass Index and Cognitive Function in Patients with Atrial Fibrillation J. Interv. Cardiol. (IF 2.1) Pub Date : 2022-12-14 Li Guo, Ping Yin, Xiangting Li, Xin Wang, Jing Xue, Wenqing Wang, Dongmei Song, Guomei Xu, Miaomiao Shang, Shuai Liu, Yuanyuan Chen, Qingyun Zhang, Dandan Sun
Background. Evidence regarding the relationship between body mass index (BMI) and cognitive function was limited. Therefore, the objective of this research is to investigate whether BMI is independently related to cognitive function in Chinese patients with atrial fibrillation after adjusting for other covariates. Methods. The present study is a cross-sectional study. A total of 281 patients with atrial
-
The Impact of Kidney Function on the Slow-Flow/No-Reflow Phenomenon in Patients Treated with Primary Percutaneous Coronary Intervention: Registry Analysis J. Interv. Cardiol. (IF 2.1) Pub Date : 2022-11-30 Lidija Savic, Igor Mrdovic, Milika Asanin, Sanja Stankovic, Ratko Lasica, Gordana Krljanac, Dubravka Rajic, Damjan Simic
Objective. The objective of this study is to analyze the impact of declining kidney function on the occurrence of the slow-flow/no-reflow phenomenon in patients with ST-elevation myocardial infarction (STEMI) treated with primary PCI (pPCI), as well as the analysis of the prognostic impact of the slow-flow/no-reflow phenomenon on short- and long-term mortality in these patients. Methods. We analyzed
-
Association between the Angle of the Left Subclavian Artery and Procedural Time for Percutaneous Coronary Intervention in Patients with Acute Coronary Syndrome J. Interv. Cardiol. (IF 2.1) Pub Date : 2022-11-17 Masatsugu Miyagawa, Daisuke Fukamachi, Katsunori Fukumoto, Masaki Monden, Kurara Takahashi, Shohei Migita, Saki Mizobuchi, Yudai Tanaka, Akihito Ogaku, Yutaka Koyama, Hidesato Fujito, Riku Arai, Norio Takei, Keisuke Kojima, Korehito Iida, Nobuhiro Murata, Yasuo Okumura
Background. The effect of left subclavian artery tortuosity during percutaneous coronary intervention (PCI) in patients with acute coronary syndrome (ACS) remains unclear. Methods. Of 245 ACS patients (from November 2019 and May 2021), 79 who underwent PCI via a left radial approach (LRA) were included. We measured the angle of the left subclavian artery in the coronal view on CT imaging as an indicator
-
Selective Use of Pulmonary Vasodilators in Patients with Fontan Physiology J. Interv. Cardiol. (IF 2.1) Pub Date : 2022-11-10 Thomas Glenn, Nicole Duster, Jerry Dwek, Jose Silva-Sepulveda, Howaida G. El-Said
Background. Fontan-associated liver disease is a well-known sequela following the Fontan procedure for patients living with single-ventricle heart disease. Pulmonary vasodilators, such as phosphodiesterase type 5 inhibitors, have emerged as a potential therapeutic option for lowering central venous pressures by reducing pulmonary vascular resistance. Method. We performed a single-center retrospective
-
Prophylactic Impella CP versus VA-ECMO in Patients Undergoing Complex High-Risk Indicated PCI J. Interv. Cardiol. (IF 2.1) Pub Date : 2022-11-7 Deborah M.F. van den Buijs, Adriaan Wilgenhof, Paul Knaapen, Carlo Zivelonghi, Tom Meijers, Paul Vermeersch, Fatih Arslan, Niels Verouden, Alex Nap, Krischan Sjauw, Floris S. van den Brink
Objectives. To compare two different forms of mechanical circulatory support (MCS) in patients with complex high-risk indicated PCI (CHIP): the Impella CP system and veno-arterial extracorporeal membrane oxygenation (VA-ECMO). Background. To prevent hemodynamic instability in CHIP, various MCS systems are available. However, comparable data on different forms of MCS are not at hand. Methods. In this
-
Mesenchymal Stem Cell-Derived Extracellular Vesicles Therapy for Pulmonary Hypertension: A Comprehensive Review of Preclinical Studies J. Interv. Cardiol. (IF 2.1) Pub Date : 2022-11-4 Ji-Hong Xu, Jia-Ping Liang, Chu-Jun Zhu, Yu-Jun Lian
Pulmonary hypertension (PH) is a type of clinical pathophysiological syndrome characterized by a progressive increase in pulmonary vascular resistance and subsequent progressive failure of the right heart function, and is a common complication of many diseases. Mesenchymal stem cells (MSCs) autonomously home to sites damaged by disease, repair damaged tissues, and participate in the regulation of systemic
-
Construction of a Clinical Predictive Model of Left Atrial and Left Atrial Appendage Thrombi in Patients with Nonvalvular Atrial Fibrillation J. Interv. Cardiol. (IF 2.1) Pub Date : 2022-11-4 Lei Yin, Changjian He, Huixin Zheng, Jianshuai Ma, Jinting Liu, Xiaohong Zhang, Ruiqin Xie
Background. The purpose of this study was to investigate the risk factors of left atrial (LA) or left atrial appendage (LAA) thrombi in patients with nonvalvular atrial fibrillation (NVAF) and to establish and validate relevant predictive models. It might improve thromboembolic risk stratification in patients with NVAF. Methods. This study retrospectively included 1210 consecutive patients with NVAF
-
Four-Year Outcomes of Left Main Percutaneous Coronary Intervention with a Bioresorbable Scaffold in the Circumflex Ostium J. Interv. Cardiol. (IF 2.1) Pub Date : 2022-10-31 Andrejs Erglis, Inga Narbute, Dace Sondore, Sanda Jegere, Indulis Kumsars, Andis Dombrovskis, Karlis Grikis, Ieva Briede, Kristine Dombrovska, Karlis Trusinskis, Alona Grave, Martins Erglis, Martins Kalejs, Peteris Stradins, Uldis Strazdins
Objectives. The study aimed to investigate the long-term outcomes of a double stent scaffold strategy in patients with left main (LM) bifurcation lesions involving the ostium of the left circumflex artery (LCX), utilizing a drug-eluting stent (DES) in the LM extending into the left anterior descending artery (LAD) and a bioresorbable vascular scaffold (BVS) in the LCX ostium. Background. The high occurrence
-
Effect of TAVR Approach and Other Baseline Factors on the Incidence of Acute Kidney Injury: A Systematic Review and Meta-Analysis J. Interv. Cardiol. (IF 2.1) Pub Date : 2022-10-27 Hossam Alzu’bi, Anan Abu Rmilah, Ikram-UI Haq, Babikir Kheiri, Ahmad Al-abdouh, Bashar Hasan, Omar Elsekaily, Suhaib Jaber, Ibraheem Qaisi, Asil Yagmour, Hamada Dajani, Azza Ahmed, undefined Ahmed elhag, Kianoush Kashani, Abhishek Deshmukh
Background. Acute kidney injury (AKI) is a well-known complication following a transcatheter aortic valve replacement (TAVR) and is associated with higher morbidity and mortality. Objective. We aim to compare the risk of developing AKI after transfemoral (TF), transapical (TA), and transaortic (TAo) approaches following TAVR. Methods. We searched Medline and EMBASE databases from January 2009 to January
-
Antithrombotic Therapy Duration after Patent Foramen Ovale Closure for Stroke Prevention: Impact on Long-Term Outcome J. Interv. Cardiol. (IF 2.1) Pub Date : 2022-10-27 Joelle Kefer, Karlien Carbonez, Sophie Pierard, François-Pierre Mouthuy, Andre Peeters, Cedric Hermans, Catherine Lambert, Christophe DeMeester, Thierry Sluysmans, Agnes Pasquet
Background. The optimal duration of antithrombotic therapy (ATT) after patent foramen ovale (PFO) closure remains under debate. This study sought to compare the clinical outcome of patients receiving antithrombotic agents for a short (6 months) versus extended (>6 months) period after the procedure. Methods. This was a retrospective cohort study using a propensity score matching analysis on 259 consecutive
-
Balloon-Expandable TAVR Bioprostheses: Area or Perimeter Sizing? A Prospective Pilot Study J. Interv. Cardiol. (IF 2.1) Pub Date : 2022-10-18 Jonathan Halim, Peter den Heijer, Jeroen Vos, Bas E. Schölzel, Martijn Meuwissen, Ben van den Branden, Andreas Baumbach, Alexander J. J. Ijsselmuiden
Objective. In TAVR, area sizing is used for balloon-expandable (BE) valves, whereas self-expanding valves are sized to annulus perimeter. For BE valves, this seems illogical: these frames force a circular shape even on an ellipsoid annulus. This can potentially lead to relative undersizing when area sizing is being applied. We developed a perimeter-based sizing algorithm to evaluate the safety and
-
Uric Acid to High-Density Lipoprotein Cholesterol Ratio is a Novel Marker to Predict Functionally Significant Coronary Artery Stenosis J. Interv. Cardiol. (IF 2.1) Pub Date : 2022-10-13 Fanqi Li, Donghui Zhao, Qiuyu Li, Xiaolong Lin, Haoxuan Sun, Qian Fan
Background. Intermediate coronary stenosis (ICS) is defined as a visually estimated percentage of diameter stenosis ranging between 40% and 70% by conventional coronary angiography (CAG). Whether to perform percutaneous coronary intervention (PCI) for these lesions is a challenge in clinical practice. The fractional flow reserve (FFR) can guide treatment by determining the functional significance of
-
Relationship among Insulin Therapy, Insulin Resistance, and Severe Coronary Artery Disease in Type 2 Diabetes Mellitus J. Interv. Cardiol. (IF 2.1) Pub Date : 2022-9-26 Jing Song, Xinyi Xia, Ye Lu, Jing Wan, Haibing Chen, Jun Yin
Objectives.The effect of insulin therapy on coronary artery disease (CAD) remains controversial. This study aimed to analyze the association between insulin resistance and the morbidity of severe CAD in type 2 diabetes mellitus (T2DM). Methods. A total of 2044 T2DM patients aged ≥40 years were included in this cross-sectional observational study. Clinical information and laboratory results were collected
-
Declining Trend of Transapical Access for Transcatheter Aortic Valve Replacement in Patients with Aortic Stenosis. J. Interv. Cardiol. (IF 2.1) Pub Date : 2022-09-19 Sumit Sohal,Harsh Mehta,Krishna Kurpad,Sheetal Vasundara Mathai,Rajiv Tayal,Gautam K Visveswaran,Najam Wasty,Sergio Waxman,Marc Cohen
Introduction The last decade has witnessed major evolution and shifts in the use of transcatheter aortic valve replacement (TAVR) for severe aortic stenosis (AS). Included among the shifts has been the advent of alternative access sites for TAVR. Consequently, transapical access (TA) has become significantly less common. This study analyzes in detail the trend of TA access for TAVR over the course
-
Sex Difference in Coronary Artery Spasm Tested by Intracoronary Acetylcholine Provocation Test in Patients with Nonobstructive Coronary Artery Disease. J. Interv. Cardiol. (IF 2.1) Pub Date : 2022-09-09 Ji Young Park,Se Yeon Choi,Seung-Woon Rha,Byoung Geol Choi,Yung-Kyun Noh,Yong Hoon Kim
Introduction Cardiovascular diseases manifest differently in men and women. The purpose of this study is to compare the sex difference in the characteristics of coronary artery spasm (CAS) in patients with nonobstructive cardiovascular disease (NOCVD) and the clinical outcomes in accordance with sex in CAS patients. Methods The study analysed 5,491 patients with NOCVD who underwent an acetylcholine
-
Upper Extremity Function following Transradial Percutaneous Coronary Intervention: Results of the ARCUS Trial J. Interv. Cardiol. (IF 2.1) Pub Date : 2022-09-06 Eva M. Zwaan, Elena S. Cheung, Alexander J. J. IJsselmuiden, Carlo A. J. Holtzer, Ton A. R. Schreuders, Marcel J. M Kofflard, J. Henk Coert
Objectives. To determine the incidence of upper extremity dysfunction (UED), after a transradial percutaneous coronary intervention (TR-PCI). Background. Transradial approach (TRA) is the preferred approach for coronary interventions. However, upper extremity complications may be underreported. Methods. The ARCUS was designed as a prospective cohort study, including 502 consecutive patients admitted
-
Management of Failed Bioprosthetic Aortic Valves: Mitigating Complications and Optimizing Outcomes J. Interv. Cardiol. (IF 2.1) Pub Date : 2022-09-02 Elizabeth L. Norton, Alison F. Ward, Adam Greenbaum, Kendra J. Grubb
The use of bioprosthetic prostheses during surgical aortic valve replacements has increased dramatically over the last two decades, accounting for over 85% of surgical implantations. Given limited long-term durability, there has been an increase in aortic valve reoperations and reinterventions. With the advent of new technologies, multiple treatment strategies are available to treat bioprosthetic valve